GLP-1 RA medications used in this patient population significantly lowered the risk of atrial fibrillation-related events for patients with diabetes, atrial fibrillation (AF), and obesity, with a particular benefit observed for those with severe obesity (TRANSFORM-AF study, Heart Rhythm 2025
AI-powered systems now simulate multiple design scenarios and forecast outcomes, significantly reducing the need for repetitive laboratory testing
Future studies should prioritize translational research efforts that bridge preclinical discoveries with clinical application, as well as investigate APAP-induced hepatotoxicity across diverse demographic and physiological subgroups
MICHELLE: You know, we'reyeah
Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizonsa scoping review